GILEAD SCIENCES, INC. Other Current Assets
GILEAD SCIENCES, INC. (GILD) had Other Current Assets of $1.06 billion as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2017-02-27
- 2016-12-31: Other Assets, Current $1.06B.
- 2016-09-30: Other Assets, Current $820.00M.
- 2016-06-30: Other Assets, Current $517.00M.
- 2016-03-31: Other Assets, Current $259.00M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2016-12-31 | $1.06B 10-K · filed 2017-02-27 | |
| 2016-09-30 | $820.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $517.00M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $259.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $505.00M 10-K · filed 2017-02-27 | $506.00M 10-K · filed 2016-02-24 |
| 2015-09-30 | $490.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $553.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $761.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $472.00M 10-K · filed 2016-02-24 | |
| 2014-09-30 | $267.25M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $199.36M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $201.01M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $91.00M 10-K · filed 2015-02-25 | $91.92M 10-K · filed 2014-02-25 |
| 2013-09-30 | $109.19M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $176.35M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $217.75M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $84.30M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $144.18M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $226.90M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $175.63M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $126.85M 10-Q · filed 2012-11-06 | |
| 2011-09-30 | $115.64M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $85.02M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $96.08M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $116.24M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $111.65M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $243.55M 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $139.88M 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $66.89M 10-K · filed 2011-02-28 | |
| 2009-09-30 | $59.71M 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $78.13M 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $126.07M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |